Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Diabetes Care
|
June 29, 2005
Effect of raloxifene on serum triglycerides in women with a history of hypertriglyceridemia while on oral estrogen therapy
Molly C Carr, Robert H Knopp, John D Brunzell, et al.
Lancet (London, England)
|
June 25, 2025
Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial
Thomas Blevins, Dominik Dahl, Federico C Pérez Manghi, et al.
The New England Journal of Medicine
|
September 10, 2024
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
Carol Wysham, Harpreet S Bajaj, Stefano Del Prato, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 8, 2009
Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study
Christine G Lee, Molly C Carr, Susan J Murdoch, et al.
Diabetes Research and Clinical Practice
|
July 7, 2017
Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy
Philip D Home, Bo Ahrén, Jane E B Reusch, et al.
British Journal of Pharmacology
|
February 13, 2023
Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failure
Petra Verdino, Stacey L Lee, Fariba N Cooper, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Diabetes Care
|
June 29, 2005
Effect of raloxifene on serum triglycerides in women with a history of hypertriglyceridemia while on oral estrogen therapy
Molly C Carr, Robert H Knopp, John D Brunzell, et al.
Lancet (London, England)
|
June 25, 2025
Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial
Thomas Blevins, Dominik Dahl, Federico C Pérez Manghi, et al.
The New England Journal of Medicine
|
September 10, 2024
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
Carol Wysham, Harpreet S Bajaj, Stefano Del Prato, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 8, 2009
Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study
Christine G Lee, Molly C Carr, Susan J Murdoch, et al.
Diabetes Research and Clinical Practice
|
July 7, 2017
Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy
Philip D Home, Bo Ahrén, Jane E B Reusch, et al.
British Journal of Pharmacology
|
February 13, 2023
Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failure
Petra Verdino, Stacey L Lee, Fariba N Cooper, et al.
Page
of 3